Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
AstraZeneca
Johnson and Johnson
Colorcon
Medtronic

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

CEPHALEXIN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Cephalexin, and what generic alternatives are available?

Cephalexin is a drug marketed by Alkem Labs Ltd, Apothecon, Aurobindo Pharma Ltd, Barr, Belcher Pharms, Facta Farma, Hikma, Ivax Sub Teva Pharms, Lupin, Orchid Hlthcare, Purepac Pharm, Stevens J, Sun Pharm Inds (in), Sun Pharm Inds Ltd, Teva, Yoshitomi, Yung Shin Pharm, Hikma Pharms, and Vitarine. and is included in fifty NDAs.

The generic ingredient in CEPHALEXIN is cephalexin. There are twenty-nine drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the cephalexin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cephalexin

A generic version of CEPHALEXIN was approved as cephalexin by TEVA on February 13th, 1987.

  Free Forever Trial

Drug patent expirations by year for CEPHALEXIN
Drug Prices for CEPHALEXIN

See drug prices for CEPHALEXIN

Drug Sales Revenue Trends for CEPHALEXIN

See drug sales revenues for CEPHALEXIN

Recent Clinical Trials for CEPHALEXIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San FranciscoPhase 2
The Plastic Surgery FoundationPhase 2
Canadian Association of Emergency PhysiciansPhase 4

See all CEPHALEXIN clinical trials

Pharmacology for CEPHALEXIN
Medical Subject Heading (MeSH) Categories for CEPHALEXIN

US Patents and Regulatory Information for CEPHALEXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr CEPHALEXIN cephalexin TABLET;ORAL 062826-001 Aug 17, 1987 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Yoshitomi CEPHALEXIN cephalexin CAPSULE;ORAL 062872-001 Jun 20, 1988 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Sun Pharm Inds (in) CEPHALEXIN cephalexin CAPSULE;ORAL 062791-002 Jun 11, 1987 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Barr CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 062778-001 Aug 6, 1987 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Dow
Johnson and Johnson
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.